Avantor, Inc. (AVTR)
15.53
-0.09
(-0.58%)
USD |
NYSE |
Nov 13, 16:00
15.53
0.00 (0.00%)
After-Hours: 19:59
Avantor Price to Book Value : 1.803 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.814 |
| November 11, 2026 | 1.827 |
| November 10, 2026 | 1.808 |
| November 09, 2026 | 1.848 |
| November 06, 2026 | 1.796 |
| November 05, 2026 | 1.758 |
| November 04, 2026 | 1.817 |
| November 03, 2026 | 1.810 |
| November 02, 2026 | 1.813 |
| October 30, 2026 | 1.864 |
| October 29, 2026 | 1.937 |
| October 28, 2026 | 1.938 |
| October 27, 2026 | 1.989 |
| October 26, 2026 | 2.008 |
| October 23, 2026 | 2.008 |
| October 22, 2026 | 1.992 |
| October 21, 2026 | 2.004 |
| October 20, 2026 | 1.93 |
| October 19, 2026 | 1.892 |
| October 16, 2026 | 1.907 |
| October 15, 2026 | 1.868 |
| October 14, 2026 | 1.823 |
| October 13, 2026 | 1.806 |
| October 12, 2026 | 1.799 |
| October 09, 2026 | 1.820 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.787 |
| October 07, 2026 | 1.782 |
| October 06, 2026 | 1.792 |
| October 05, 2026 | 1.836 |
| October 02, 2026 | 1.781 |
| October 01, 2026 | 1.745 |
| September 30, 2026 | 1.748 |
| September 29, 2026 | 1.831 |
| September 28, 2026 | 1.837 |
| September 25, 2026 | 1.832 |
| September 24, 2026 | 1.848 |
| September 23, 2026 | 1.774 |
| September 22, 2026 | 1.795 |
| September 21, 2026 | 1.814 |
| September 18, 2026 | 1.865 |
| September 17, 2026 | 1.906 |
| September 16, 2026 | 1.876 |
| September 15, 2026 | 1.855 |
| September 14, 2026 | 1.822 |
| September 11, 2026 | 1.780 |
| September 10, 2026 | 1.788 |
| September 09, 2026 | 1.788 |
| September 08, 2026 | 1.832 |
| September 04, 2026 | 1.799 |
| September 03, 2026 | 1.825 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Champions Oncology, Inc. | 16.73 |
| Medpace Holdings, Inc. | 31.17 |
| Personalis, Inc. | 8.003 |
| Adaptive Biotechnologies Corp. | 26.63 |
| 10X Genomics, Inc. | 9.128 |
Price to Book Value Related Metrics
| PE Ratio | 31.30 |
| PS Ratio | 1.588 |
| Price to Free Cash Flow | 23.99 |
| Price | 15.53 |
| Earnings Yield | 3.19% |
| Market Cap | 10.52B |
| Operating PE Ratio | 19.21 |
| Normalized PE Ratio | 28.06 |